About Leucine
Leucine is a company based in Wilmington (United States) founded in 2015 by Vivek Gera and Mustaq Singh Bijral. Leucine has raised $7.68 million across 3 funding rounds from investors including Ecolab, Pravega Ventures and Axilor Ventures. Leucine offers products and services including Manufacturing Execution System, Quality Management System, Laboratory Execution System, Batch Execution, and AI Investigator. Leucine operates in a competitive market with competitors including Advarra, Cogniac, Qualio, MasterControl and LANDING AI, among others.
- Headquarter Wilmington, United States
- Founders Vivek Gera, Mustaq Singh Bijral
- Stage Minicorn
-
Sectors
TechnologyHealthcare Industrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leucine Medtech Private Limited
- Date of Incorporation 22 Apr, 2015
- Jurisdiction Sri Ganganagar, Rajasthan, India
-
Annual Revenue
$95.59 K (USD)-28.9as on Mar 31, 2023
-
Net Profit
$85.14 K (USD)133.16as on Mar 31, 2023
-
EBITDA
$87.98 K (USD)133.96as on Mar 31, 2023
-
Total Equity Funding
$7.68 M (USD)
in 3 rounds
-
Latest Funding Round
$7 M (USD), Series A
Oct 16, 2023
-
Investors
Ecolab
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Leucine
Leucine offers a comprehensive portfolio of products and services, including Manufacturing Execution System, Quality Management System, Laboratory Execution System, Batch Execution, and AI Investigator.
Streamlines workflows for efficient batch execution and compliance
Manages documentation and automates compliance risk alerts
Orchestrates operations for faster turnaround and error reduction
Digitizes manufacturing workflows to ensure accurate execution
Accelerates investigations for regulatory and quality issues
Funding Insights of Leucine
Leucine has successfully raised a total of $7.68M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $7 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Leucine
Leucine has secured backing from 6 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Ecolab, Pravega Ventures and Axilor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Financial services, strategic advisory, and partnerships in investments.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage startups in technology sectors.
|
Locked | Locked | Locked | |
|
Startups are accelerated globally without sector restrictions through structured programs.
|
Locked | Locked | Locked |
Investor details for Leucine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Leucine
Investment portfolio details for Leucine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Leucine
Detailed financials for Leucine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leucine Comparisons
Peer comparison for Leucine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Leucine
Leucine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advarra, Cogniac, Qualio, MasterControl and LANDING AI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Global research compliance services including IRB and consulting are provided.
|
|
| Locked | Locked | Locked |
AI-based platform is utilized for managing visual operations in businesses.
|
|
| Locked | Locked | Locked |
Web-based quality management software is delivered for life sciences firms.
|
|
| Locked | Locked | Locked |
Provider of governance, risk and compliance solutions for life sciences industries
|
|
| Locked | Locked | Locked |
AI-based platform for identifying defects
|
|
| Locked | Locked | Locked |
Legit is recognized as a pioneer in privacy and data protection, offering innovative RegTech solutions.
|
Detailed competitors of Leucine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leucine
Complete news archive for Leucine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leucine
Leucine was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Leucine is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Vivek Gera is the current CEO of Leucine. They have also founded this company.
Leucine is a funded company, having raised a total of $7.68M across 3 funding rounds to date.
Annual revenue of Leucine is $95.59K as on Mar 31, 2023.
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory. The platform integrates manufacturing execution, quality management, and laboratory operations into a unified digital ecosystem. It offers solutions for batch execution, quality control, environmental monitoring, and instrument management. The software aims to streamline workflows, ensure regulatory compliance, and optimize operational efficiency within pharmaceutical facilities.
Leucine's top competitors include Advarra, Qualio and MasterControl.
Leucine offers Manufacturing Execution System, Quality Management System, Laboratory Execution System, Batch Execution, and AI Investigator.
Leucine has 6 investors. Key investors include Ecolab, Pravega Ventures, Axilor Ventures, Techstars, and Dilipkumar Khandelwal.
The valuation of Leucine is $3.22M as of Jun 2020.